Catalyst Wire Dossier Catalyst Wire Dossier

Autologous Mesenchymal Stem Cells with Biomaterial Scaffold

Autologous mesenchymal stem cells with biomaterial scaffold · INSERM
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous Mesenchymal Stem Cells with Biomaterial Scaffold, covering 2025-01-30 to 2025-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing [Phase 2]

See pricing